Intrinsiqq
Ipsen logo

Ipsen Quality Score

IPN.XPAR

⊜ Compare
Quality60

Business quality is the primary weakness (avg 55/100). Valuation is the relative bright spot.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
60/100
29.3x

25–30x, paying a growth premium

Cash Flow Multiple
90/100
15.9x

Under 20x cash flow, well covered

Revenue Growth
70/100
7.6%

5–10% CAGR, steady but not exceptional

Cash Flow Growth
50/100
4.1%

2–5% CAGR, growing but slowly

Business Quality & Capital Allocation

Share Dilution
60/100
0.3%

Mild dilution under 2%

Margin Trend
0/100
-3.6pp

Contracted >2pp, margin pressure

Capital Structure
100/100
-€659M

Net cash position, no leverage concern

2022
€1.20B
€613M
2023
€539M
€374M
2024
€679M
€427M
2025
€1.53B
€867M
CashDebt
Return on Capital
60/100
14.8%

10–15%, respectable returns

Customize WeightsPremiumUpgrade

Ipsen (IPN.XPAR) quality: score, margins and returns

Ipsen (IPN.XPAR) scores 60/100 on Intrinsiqq's quality score (a solid business), a weighted blend of 8 metrics each scored 0 to 100, on 24.1% operating margins and 14.8% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Ipsen (IPN.XPAR) a high-quality business?+

Ipsen scores 60 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a solid business on these measures. Recent figures include a 24.1% operating margin and a 14.8% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Ipsen's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from IPN.XPAR's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Ipsen scores well and where it falls behind.

What is Ipsen's return on invested capital (ROIC)?+

Ipsen earns about 14.8% on its invested capital, which is solid. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to IPN.XPAR's margins and growth on this scorecard to judge durability.

How profitable is Ipsen?+

Ipsen runs an operating margin of about 24.1% and a net margin of about 11.3%. Revenue has grown at roughly 9.3% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Peers

Drug Manufacturers - Specialty & Generic · Pick stocks to compare with IPN.XPAR

CompareIntrinsic value
BIM.XPARbioMérieux SA
€97.65+3.06%65
ORP.XPAROrpea
€10.20+2.93%26
GDS.XPARRamsay Générale de Santé SA
€8.62-1.37%49
CLARI.XPARClariane SE
€3.31+3.43%45
EMEIS.XPAREmeis SA
€10.20+2.93%56
LNA.XPARLNA Santé SA
€25.50+4.51%46
EAPI.XPAREuroapi S.A.S.U.
€0.82+2.11%46
GBT.XPARGuerbet SA
€6.26-0.95%38

Held by ETFs

IPN.XPAR is in 83 US ETFs. The largest of them, with IPN.XPAR's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IPN.XPAR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.